IXC below Example of that is NEU Investor Presentation, page-3. . **Close price adjusted for splits and dividend and/or capital gain distributions. , page-4. ASX - Short Term Trading. Appreciate your input Dr T. Charts. 5¢ Sentiment: Buy Disclosure: Held Created with Sketch. ASX - By Stock. ASX - By Stock. 1. ASX - General. Invex Receives Approval for Paediatric Plan from the EMA, page-3. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. . . What would you like to pay the world leader in IIH science as CSO, and how much of that salary you would expect to be spent on market to buy shares? Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself, Publication of Invex IIH Phase II Pressure Trial Results. 6% $DLM 50. A handy 10 bags from here with seemingly little risk. . Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. See page-34. I think having this out we can discuss on the way. . . 0 Great. Share A few weeks ago in the lead up to the Phase 2 results invex included this slide on their slide deck - 'average 42 million increase in market cap after positive Phase 2 results'. 1950. ASX - Short Term Trading. Latest Posts. ASX - General. 375,000. Of course IXC isnt the stock market but its coincidental that selling has stopped around this 17 cents mark which aligns with the old trend line from back in the days. Forgot Client ID or Password? If you're a CommBank customer, you can access CommSec from Netbank. Join the HotCopper ASX share market forum today for free. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 147,415. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. 0. 5¢ Sentiment: Buy Disclosure: Held. Very impressive. 64440. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. , page-5. Market . View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. Last edited by ejjwj: 28/06/23. EGREcoGraf partners with VinES Energy for pioneering Battery Anode Material Facility in Vietnam. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Forums. Created with Sketch. ASX - Day Tradingis invex releasing 2. Created with Sketch. Very tempted to buy them back today at 19c. IXC Valuation Report MST. ASX - By Stock. Met primary endpoints for phase 2 trials. June 23 (Reuters) - Invex Therapeutics Ltd (IXC) : GRANTING OF ORPHAN DRUG DESIGNATION FOR EXENATIDE IN TREATMENT OF MODERATE TO SEVERE TRAUMATIC BRAIN. As thread states post your questions here and let’s start compiling a list. Created with Sketch. wonder if the GLP-1 agonist referred to in this media release. Zillow has 23383 homes for sale in British Columbia. Share. , page-2. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. Created with Sketch. Market . 5¢ Sentiment: Buy Disclosure: Held Ive compared IXC to NEU before and believe we approx. ASX - General. I'm doing my bit lolRecent success of NEU and ALA just goes to show there is money floating around, all IXC needs is a. 3¢. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool. Latest Posts Forums iShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Discover historical prices for IXC. Information. ASX - By Stock. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. ASX - By Stock. Join HotCopper today. Invex Files Pre-IND/Type B Meeting Request with US FDA IXC is a long term play mate, not a daytraders plaything as too illiquid. ASX - Day Trading. 333334. , page-3. ASX - By Stock. Created with Sketch. Created with. The IXC stock may trade low due to this wider macroeconomic issues, but the business itself is top 5% to its peers merely from the fact of having no future funding requirements and that if the trial is a success having close to immediate revenues and default alive status via Peptron manufacturing contract fulfilling demand on potential FDA. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. IXC Valuation Report MST. View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. LoginJoin Now. . Australian finance news, stock quotes, currency information and blogs0. 0¢ Sentiment: Buy Disclosure: Held. IXC Price at posting: 38. 1950. . You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. no point selling now. ASX - Day Trading. $100-200k might be the minimum for the market to take notice. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. I think having this out we can discuss on the way. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-5. ASX - By Stock. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. Market . , page-188. Timeline Annotations of the IXC Chart Story Thus Far - IXC IPO'd in mid 2019 with Phase II data due Mid 2020, stock performs very well on IPO with tight T20 - The stock rose in anticipation for the Mid 2020 Phase II data read out in early 2020 - Before crashing alongside the Covid 19 Market Crash Hysteria in March 2020 AND all volume the last 18 months has led to a higher T20 ownership) meanwhile we have a mere 3 posts regarding an IXC job listing for a CMO that's description can be interpreted as hinting at a second indication. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. Market . A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak:Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. Jellyroll, arkangel, CD, balkanbroker to name a few have laid out some pretty compelling thesis' on where IXC will be heading. ASX - Day Trading. Learn more. Forums. Lucky for you all IXC still sits at only 60 cents. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. Notice of Annual General Meeting/Proxy FormInvex Receives Written Response from FDA on Type C MeetingNotification of cessation of securities - IXC. Created with Sketch. Created with Sketch. Latest Posts. Theres alot of breakdowns above that are yet to be backtested. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 1 Upvote. . , page-136. Market . 5¢ INVEX THERAPEUTICS LTD - Discussion. Forums. , page-5. ASX - Day TradingChange in substantial holding. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. ASX - Day TradingInvex Files Pre-IND/Type B Meeting Request with US FDA, page-2. Charts. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Latest Posts. 20 to $7. Thought that this would be worthy of its own thread, a great starting place for those new to IXC and arguably the best presentation to date, Worth a. , page-2. 5¢ Sentiment: Hold Disclosure: Held IXC Valuation Report MST. . ASX - By Stock. . Join the HotCopper ASX share market forum today. Withdrawal of AGM Resolutions, page-2. Created with Sketch. Report to HotCopper and itll be the end of it, cheers. Created with Sketch. ASX - Short Term Trading. , page-32. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited) At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Forums. ASX - By Stock. 40. is 19. Market . Share 14 mill MC 22 mill cash Like I said they might have gotten rid of Jason and Alex to streamline costs, smartest thing to do is JV with some large pharma let them run trials we get 40% royalty and they get 60% of drug (sell it to them). 1950. 3¢. There can't be many left who have a positive association with this stock (apart from seed investors), so I don't think token $10-20k director purchases will change anything. **Close price adjusted for splits and dividend and/or capital gain distributions. Charts. We are a team of expert financial advisers each specialising in different, yet complementary areas. 30 Haven’t supported share price since then on market . Invex Granted Type C Meeting with FDA, page-2. 0. Here come the vultures. Created with Sketch. . 0 Million. . Market . Last updated 15. IXC Valuation Report MST. ASX - Day TradingCreated with Sketch. ASX - Day Trading. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Created with Sketch. Created with Sketch. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. . . Fully funded. . . ASX - Short Term Trading. Backed by Twiggy. ASX - By Stock. . 5mill options have been issued at a strike price of $1 First lot 250k to a soph. 1. Target our investor community with our suite of Hotcopper Advertising opportunities. 5 cents. , page-3. ASX - Day Trading. Forums. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. IXC. . 0¢ Sentiment: Buy Disclosure: HeldHotCopper has news, discussion, prices and market data on GENESIS MINERALS LIMITED. 1. . Latest Posts ForumsThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. IXC Price at posting: 37. Created with Sketch. . Created with Sketch. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . Target our investor community with our suite of Hotcopper Advertising. , page-2. ASX - General. ASX - By Stock. Cold Comfort Ice Cream Company, Victoria, British Columbia. ASX - Day TradingHi all, I would like to preface the below summary written prior to the research links as being a heavily simplified summary of the company and the. Share Appreciate the commentary and post. Forex. 59). @FullMoonFever Another chart request if you are up for it please thanks in advance, page-6. But posts 3-4 times a day that are the same charts we can all see, about a -3% move on $10k volume, paired with hysteria and paranoia, its just not. Created with Sketch. Also took placement stock @$1. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - By Stock. Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. Advertise on HotCopper. Webinvest Pty Ltd<Olsb Unit A/C>. . Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. IXC has not had a decent bounce at all as yet, maybe still some sellers lurking. Created with Sketch. . The company can always acquire something new or do some capital returns. , page-4. Investor PresentationInvex Successfully Concludes Protocol Assistance with EMACreated with Sketch. . AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. 06KBNotification of cessation of securities - IXC. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. Although, IXC is trading about 3-4x lower than what I expect it to be. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. 50%. ASX - General. 10 Upvote. STN Saturn Metals reports high-grade gold intersections and visible gold at Apollo Hill, WAInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Created with Sketch. Invex Therapeutics Ltd. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with Sketch. , page-17. 15M !Invex to Present at Bell Potter Healthcare ConferenceNotice of Annual General Meeting/Proxy Form, page-3. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. This is a complete waste of time and posting space - give yourself a break man and forget about trying to predict what is completely un-predictable. Created with Sketch. IXC Price at posting: 79. , page-3. Advertise on HotCopper. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. IXC Valuation Report MST. You are still able to buy a potential multi BILLION dollar company in the 50 mill MC range. ASX - By Stock. 6million shares?, and if so is anyone worried about this, release date 29th. Join the HotCopper ASX share market forum today for free. ASX - By Stock. Proposed Capital Return to Shareholders of $14. ASX - Day Trading. ASX - Day Trading. 0. Target our investor community with our suite of Hotcopper Advertising opportunities. Australia's largest stock trading and investment forum Australia's #1 stock forumInvestor PresentationMRDMount Ridley Mines REE Project: Drilling confirms continuous high-grade mineralisation. 76 (-1. It certainly has been a hard few months for the biotech sector with PEB, NYR, NOX and now IXC all having prangs. Share Not unexpected. Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. Orphan drug status. Market . It's essentially a cashed up shell company right now it. , page-2. Join the HotCopper ASX share market forum today for free. 2. , page-3. Charts. IXC Price at posting: 44. Friday we moved 55% off 690k volume. Created with Sketch. With a team of 68. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. June 15 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES WRITTEN RESPONSE FROM FDA ON TYPE C MEETING ON PHASE III CLINICAL TRIAL DESIGN FOR. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Latest Posts. ASX - Day TradingI sold around half my shares yesterday at 25c. Created with Sketch. International Markets. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Latest Posts. Andrew Forrest , or his entities have been involved with IXC since inception. Daily bounced well off support and now slowly creeping upId like to see a range develop now between say 18 - 23 before next bit of news, page-517. Latest Posts. ASX - Short Term Trading. Read in the announcement, has changed name and he has bought more ixc, page-2. The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Management ticking boxes while shareholders continue to have a golden opportunity to invest near all time lows in a company that has continually de-risked the fundamentals thesis. 5% last year. Join the HotCopper ASX share market forum today for free. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Forums. A new thread to put trading comments / reasoning / opinions in. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. More. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. The fact it recovered and closed about the 1. Appendix 4E and Annual Report, page-2. Latest Posts. 147,415. Created with Sketch. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - Day TradingCreated with Sketch. Created with Sketch. Currency in USD 38. AX stock on Yahoo Finance. Bumping up this thread as $3. 6% $DLM 50. Forums. IXC Price at posting:. Report Created with Sketch. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. Results of MeetingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 333334. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. I think having this out we can discuss on the way. Charts. IXC Price at posting: $1. ASX - Day Trading. Click for more information. Learn how it impacts everything we do. Last edited by jellyroll: 27/02/23. Created with Sketch. Share I've got no issues with it. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. 0 Great. June 29 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES UK APPROVAL TO COMMENCE PHASE III TRIAL CLINICAL TRIAL FOR PRESENDIN DRUG FOR. ASX - By Stock. The Chart: An Opportunity at these Levels?Timeline Annotations of the IXC Chart Story Thus Far- IXC IPO'd in mid 2019 with Phase II data due Mid 2020,. Notice of Investor Call and Presentation, page-3. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of.